重编程
认知
神经科学
睡眠(系统调用)
表型
医学
小胶质细胞
生物
疾病
免疫学
受体
认知功能衰退
小RNA
生物信息学
睡眠不足
作者
Jun Zhang,Hongyan Zhou,Fang Sun,Ping Yang,Kailu Li,管春香,Jiaxiu He,Zhao Zhong,Shihui Sun,Qi Wu,Jinyuan Meng,Hua Xu,Shaochun Guo,Peigang Ji,Kehinde Alare,Gang Zhu,Changjun Su,Fan Chen
标识
DOI:10.1186/s12964-026-03291-3
摘要
Sleep deprivation (SD) drives persistent neuroinflammation and cognitive impairment, yet the underlying cellular and molecular mechanisms remain incompletely understood. Using single-cell transcriptomics of SD mouse brains, we identify a microglial phenotype shift characterized by downregulation of the homeostatic marker Tmem119 and upregulation of the disease-associated gene APOE . To therapeutically reverse this pathology, we engineered a biomimetic nanoplatform (ATABP) that co-delivers Tmem119-encoding plasmid DNA and an APOE-modulating agent. The platform is cloaked with activated microglial membrane for inflammation-directed homologous targeting, and functionalized with ApoA1-mimetic peptides to enable lymphatic trafficking for brain delivery, while co-delivering the pleiotropic APOE-modulating agent probucol. In SD mice, ATABP treatment restored the homeostatic microglial phenotype, attenuated neuroinflammation, reduced endogenous amyloid-β accumulation, and rescued cognitive performance with no detectable toxicity across the parameters and timeframes tested. This study identifies the Tmem119/APOE imbalance as a candidate driver of SD-induced neuropathology and demonstrates that lymph-targeted biomimetic nanodelivery offers a promising strategy for microglial reprogramming in SD and potentially other neurological conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI